Actavis pharmaceuticals unaffected by Iceland crisis
Pharmaceutical giant Actavis has released a statement saying it’s business as normal for the global generic drugs company.
Actavis has said that its operations will not be impacted by the current financial turmoil in Iceland.
Actavis, which has its headquarters in Reykjavik, is a leading generic pharmaceuticals manufacturer with operations in 40 countries and 11,000 employees.
The company states that “only 1% of Actavis’ revenues are generated in Iceland” and that it is “not exposed to the Icelandic banks in regards to funding or normal banking facilities”.
The Icelandic government recently nationalized all the country’s major banks with the country’s currency, the krona, seeing a sharp fall in value.
Actavis states that its banking operations are with international banks which are not exposed to the current events in Iceland, and that its books are in euros.
“The global financial crisis does not impact our normal course of business, and we will remain focused on providing quality products to our customers,” the statement reads.
For more information on Actavis generic pharmaceuticals visit www.actavis.com.
- Contact Information
- Hjordis Arnadottir
- Director, External Communications
- Actavis Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.